Track insider trading activity in real time. Regulatory filing analysis that surfaces the most telling signals about company health directly from executive actions. Nobody knows a company's prospects better than its leadership.
As of 2026-04-06, Fortress Biotech Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock (FBIOP) trades at a current price of $13.62, marking a 0.26% gain in recent trading. This analysis examines key technical levels, prevailing market context, and potential near-term price scenarios for the preferred equity instrument, with a focus on observable market trends rather than predictive calls. No recent earnings data specific to this preferred stock series is available at the time of
Is Fortress (FBIOP) Stock Discounted Now | Price at $13.62, Up 0.26% - Synthetic Long
FBIOP - Stock Analysis
3963 Comments
519 Likes
1
Wajiha
Regular Reader
2 hours ago
Absolute mood right there. 😎
👍 237
Reply
2
Mykhal
Consistent User
5 hours ago
Too bad I wasn’t paying attention earlier.
👍 129
Reply
3
Areya
Experienced Member
1 day ago
This feels like I just unlocked confusion again.
👍 112
Reply
4
Glatha
Daily Reader
1 day ago
Anyone else here feeling the same way?
👍 62
Reply
5
Maiyer
Experienced Member
2 days ago
Trading activity is relatively high, with both long and short-term strategies being employed by investors.
👍 19
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.